Comparing Antegrade Dissection and Re-entry Versus Retrograde Approach in Coronary Artery Blockage Treatment
A Study on Procedure Success, Time, and Operator Stress in CTO Percutaneous Coronary Intervention
Led by National Institute of Cardiology, Warsaw, Poland · Updated on 2026-01-02
74
Participants Needed
3
Research Sites
26 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are evaluating two approaches for coronary chronic total occlusion CTO percutaneous coronary intervention PCI antegrade dissection and re-entry ADR versus the retrograde strategy. The study aims to compare procedural outcomes such as total procedure time, success rates of guidewire crossing, procedural complications, and stress levels experienced by interventional cardiologists. It also examines whether the retrograde approach leads to higher rates of myocardial injury or infarction based on cardiac troponin levels and cardiac magnetic resonance CMR.
Participants with difficult CTO lesions will undergo pre-procedural assessments including cardiac magnetic resonance imaging, laboratory tests for cardiac markers, and health status questionnaires. Those with failed or unattempted primary antegrade wiring will be randomly assigned to either ADR or retrograde strategy groups. Patients with successful antegrade wiring will be followed in an observational arm. After the procedure, cardiac enzyme levels and CMR will be repeated, and health status reassessed three months later. The physical and mental stress of the cardiologists performing the procedures will also be monitored.
Participants will be involved in laboratory testing before and after PCI, CMR scans within five days post-procedure, and health questionnaires at baseline and three months. Researchers will measure outcomes including procedure duration, guidewire crossing success, radiation exposure, contrast use, complications, myocardial injury and infarction, quality of life, and target lesion failure at three months. Stress indicators for physicians will be recorded during the procedure. The study lasts from procedure day through three months follow-up.
CONDITIONS
Brief Title
Antegrade Dissection and Re-entry Versus Retrograde Strategy in CTO PCI
Research Team
K
Katarzyna Istynowicz
W
Wioletta Antos
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Clinical indication for CTO PCI determined by the local heart team (presence of angina or equivalent symptoms and/or documented ischemia or viability)
Difficult native CTO lesion with J-CTO difficulty score of 2 or higher on angiography
Angiographic suitability for both ADR and retrograde strategy as assessed by 2 independent CTO PCI operators
Provided informed consent for participation in the study
You will not qualify if you...
Under 18 years of age
Acute myocardial infarction
Cardiogenic shock
Severe valvular disease
Estimated life expectancy less than 1 year
Contraindication to PCI
Allergy to contrast media
Positive pregnancy test or currently breastfeeding
Native CTO lesion with easy or intermediate difficulty score on angiography (J-CTO score less than 2)
Lack of angiographic equipoise between ADR and retrograde strategy as assessed by 2 independent CTO PCI operators
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - 1 day
Participants undergo CTO PCI using either the ADR or retrograde strategy as randomized after the initial antegrade wiring attempt. The procedure involves recanalization of the occluded coronary artery using specialized techniques.
1 procedural visit (in-person)
Post-procedural In-hospital Monitoring
Duration - Up to 5 days
Participants have cardiac biomarkers measured and cardiac magnetic resonance imaging performed within 5 days after the procedure to assess myocardial injury and infarction.
Approximately 2 visits (in-person)
Follow-up
Duration - 3 months
Participants have their health status reassessed at 3 months post-procedure to evaluate quality of life and clinical outcomes including any cardiac events.
1 follow-up visit (in-person)
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Comparing 24-Month Versus 12-Month Dual Antiplatelet Therapy After Drug-Eluting Stent Placement in Patients With High Lipoproteina Levels
Developing a 10-Minute MRI Protocol to Improve Heart Disease Diagnosis and Care
Study of Adults With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
Tracking Heart and Health Outcomes Over Time
Study of Implantable Cardioverter Defibrillator Benefits in Adults with Coronary Artery Disease and Ventricular Fibrillation After Complete Revascularization
Evaluating Intravenous YN001 Compared to Placebo in Adults Aged 18 to 80 With Coronary Atherosclerosis Receiving Cardiovascular Risk Therapy
Validating the ABCD-GENE Score to Identify Stable Coronary Artery Disease Patients Undergoing Elective PCI at Risk of Heart Injury During Procedure
Randomized Trial Comparing CT Angiography and Ultrasound Guidance for Treating Calcified Coronary Artery Disease with PCI
Study on Ultrasound Screening and Combined Treatments for Patients With Coronary and Head and Neck Artery Narrowing
Study of Factors Affecting Outcomes After Paclitaxel Drug-Coated Balloon Angioplasty in Adults with Coronary Artery Disease
Study of Yiyang Huoluo Decoction Combined with Western Medicine to Treat Coronary Heart Disease and Atherosclerosis in Older Adults
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Antegrade dissection and re-entry vs retrograde strategy in chronic total occlusion percutaneous coronary intervention: Rationale and design of the ADRENALINE randomized study.
Maksymilian P Opolski, Mateusz Spiewak, Filip Machaj...